Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 223

1.

Ileostomy for steroid-resistant acute graft-versus-host disease of the gastrointestinal tract.

Turki AT, Bayraktar E, Basu O, Benkö T, Yi JH, Kehrmann J, Tzalavras A, Liebregts T, Beelen DW, Steckel NK.

Ann Hematol. 2019 Jul 23. doi: 10.1007/s00277-019-03754-3. [Epub ahead of print]

PMID:
31338570
2.

Pre-transplant testosterone and outcome of men after allogeneic stem cell transplantation.

Radujkovic A, Kordelas L, Krzykalla J, Benner A, Schult D, Majer-Lauterbach J, Beelen DW, Müller-Tidow C, Kasperk C, Dreger P, Luft T.

Haematologica. 2019 Jul 11. pii: haematol.2019.220293. doi: 10.3324/haematol.2019.220293. [Epub ahead of print]

3.

Individual Immune-Modulatory Capabilities of MSC-Derived Extracellular Vesicle (EV) Preparations and Recipient-Dependent Responsiveness.

Kordelas L, Schwich E, Dittrich R, Horn PA, Beelen DW, Börger V, Giebel B, Rebmann V.

Int J Mol Sci. 2019 Apr 2;20(7). pii: E1642. doi: 10.3390/ijms20071642.

4.

Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation.

Toffalori C, Zito L, Gambacorta V, Riba M, Oliveira G, Bucci G, Barcella M, Spinelli O, Greco R, Crucitti L, Cieri N, Noviello M, Manfredi F, Montaldo E, Ostuni R, Naldini MM, Gentner B, Waterhouse M, Zeiser R, Finke J, Hanoun M, Beelen DW, Gojo I, Luznik L, Onozawa M, Teshima T, Devillier R, Blaise D, Halkes CJM, Griffioen M, Carrabba MG, Bernardi M, Peccatori J, Barlassina C, Stupka E, Lazarevic D, Tonon G, Rambaldi A, Cittaro D, Bonini C, Fleischhauer K, Ciceri F, Vago L.

Nat Med. 2019 Apr;25(4):603-611. doi: 10.1038/s41591-019-0400-z. Epub 2019 Mar 25.

PMID:
30911134
5.

Biology-Driven Approaches to Prevent and Treat Relapse of Myeloid Neoplasia after Allogeneic Hematopoietic Stem Cell Transplantation.

Zeiser R, Beelen DW, Bethge W, Bornhäuser M, Bug G, Burchert A, Christopeit M, Duyster J, Finke J, Gerbitz A, Klusmann JH, Kobbe G, Lübbert M, Müller-Tidow C, Platzbecker U, Rösler W, Sauer M, Schmid C, Schroeder T, Stelljes M, Kröger N, Müller LP.

Biol Blood Marrow Transplant. 2019 Apr;25(4):e128-e140. doi: 10.1016/j.bbmt.2019.01.016. Epub 2019 Jan 15. Review.

PMID:
30658222
6.

Correction to: Platelet number and graft function predict intensive care survival in allogeneic stem cell transplantation patients.

Turki AT, Lamm W, Schmitt C, Bayraktar E, Alashkar F, Metzenmacher M, Wohlfarth P, Beelen DW, Liebregts T.

Ann Hematol. 2019 Mar;98(3):811. doi: 10.1007/s00277-018-3580-6.

PMID:
30552466
7.

Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV.

Michel C, Burchert A, Hochhaus A, Saussele S, Neubauer A, Lauseker M, Krause SW, Kolb HJ, Hossfeld DK, Nerl C, Baerlocher GM, Heim D, Brümmendorf TH, Fabarius A, Haferlach C, Schlegelberger B, Balleisen L, Goebeler ME, Hänel M, Ho A, Dengler J, Falge C, Möhle R, Kremers S, Kneba M, Stegelmann F, Köhne CH, Lindemann HW, Waller CF, Spiekermann K, Berdel WE, Müller L, Edinger M, Mayer J, Beelen DW, Bentz M, Link H, Hertenstein B, Fuchs R, Wernli M, Schlegel F, Schlag R, de Wit M, Trümper L, Hebart H, Hahn M, Thomalla J, Scheid C, Schafhausen P, Verbeek W, Eckart MJ, Gassmann W, Schenk M, Brossart P, Wündisch T, Geer T, Bildat S, Schäfer E, Hasford J, Hehlmann R, Pfirrmann M.

Haematologica. 2019 May;104(5):955-962. doi: 10.3324/haematol.2018.206797. Epub 2018 Dec 4.

8.

Platelet number and graft function predict intensive care survival in allogeneic stem cell transplantation patients.

Turki AT, Lamm W, Schmitt C, Bayraktar E, Alashkar F, Metzenmacher M, Wohlfarth P, Beelen DW, Liebregts T.

Ann Hematol. 2019 Feb;98(2):491-500. doi: 10.1007/s00277-018-3538-8. Epub 2018 Nov 7. Erratum in: Ann Hematol. 2018 Dec 14;:.

PMID:
30406350
9.

Dissecting Genetic Control of HLA-DPB1 Expression and Its Relation to Structural Mismatch Models in Hematopoietic Stem Cell Transplantation.

Meurer T, Arrieta-Bolaños E, Metzing M, Langer MM, van Balen P, Falkenburg JHF, Beelen DW, Horn PA, Fleischhauer K, Crivello P.

Front Immunol. 2018 Oct 5;9:2236. doi: 10.3389/fimmu.2018.02236. eCollection 2018.

10.

Relative Impact of HLA Matching and Non-HLA Donor Characteristics on Outcomes of Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome.

Ayuk F, Beelen DW, Bornhäuser M, Stelljes M, Zabelina T, Finke J, Kobbe G, Wolff D, Wagner EM, Christopeit M, Schmid C, Ottinger H, Groth C, Faul C, Bertz H, Rachlis E, Wolschke C, Schetelig J, Horn PA, Mytilineos J, Guellstorf M, Kelsch R, Fleischhauer K, Kröger N, Bethge W.

Biol Blood Marrow Transplant. 2018 Dec;24(12):2558-2567. doi: 10.1016/j.bbmt.2018.06.026. Epub 2018 Jul 24.

PMID:
29966760
11.

Competing-risk outcomes after hematopoietic stem cell transplantation from the perspective of time-dependent effects.

Fuerst D, Frank S, Mueller C, Beelen DW, Schetelig J, Niederwieser D, Finke J, Bunjes D, Kröger N, Neuchel C, Tsamadou C, Schrezenmeier H, Beyersmann J, Mytilineos J.

Haematologica. 2018 Sep;103(9):1527-1534. doi: 10.3324/haematol.2017.183012. Epub 2018 Jun 7.

12.

Adoptive transfer of cellular immunity against cytomegalovirus by virus-specific lymphocytes from a third-party family donor.

Lindemann M, Eiz-Vesper B, Steckel NK, Tischer S, Fiedler M, Heinold A, Klisanin V, Maecker-Kolhoff B, Blasczyk R, Horn PA, Beelen DW, Koldehoff M.

Bone Marrow Transplant. 2018 Oct;53(10):1351-1355. doi: 10.1038/s41409-018-0209-2. Epub 2018 May 8. No abstract available.

PMID:
29740181
13.

Comparable results of autologous and allogeneic haematopoietic stem cell transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia in first complete molecular remission: An analysis by the Acute Leukemia Working Party of the EBMT.

Giebel S, Labopin M, Potter M, Poiré X, Sengeloev H, Socié G, Huynh A, Afanasyev BV, Schanz U, Ringden O, Kalhs P, Beelen DW, Campos AM, Masszi T, Canaani J, Mohty M, Nagler A.

Eur J Cancer. 2018 Jun;96:73-81. doi: 10.1016/j.ejca.2018.03.018. Epub 2018 Apr 18.

PMID:
29679774
14.

XplOit: An Ontology-Based Data Integration Platform Supporting the Development of Predictive Models for Personalized Medicine.

Weiler G, Schwarz U, Rauch J, Rohm K, Lehr T, Theobald S, Kiefer S, Götz K, Och K, Pfeifer N, Handl L, Smola S, Ihle M, Turki AT, Beelen DW, Rissland J, Bittenbring J, Graf N.

Stud Health Technol Inform. 2018;247:21-25.

PMID:
29677915
15.

Allogeneic haematopoietic cell transplantation offers the chance of cure for patients with transformed follicular lymphoma.

Heinzelmann F, Bethge W, Beelen DW, Stelljes M, Dreger P, Engelhard M, Finke J, Kröger N, Holler E, Bornhäuser M, Müller A, Haubitz I, Ottinger H.

J Cancer Res Clin Oncol. 2018 Jun;144(6):1173-1183. doi: 10.1007/s00432-018-2633-5. Epub 2018 Apr 5.

PMID:
29623467
16.

Microbiologic Diagnostic Workup of Acute Respiratory Failure with Pulmonary Infiltrates after Allogeneic Hematopoietic Stem Cell Transplantation: Findings in the Era of Molecular- and Biomarker-Based Assays.

Wohlfarth P, Turki AT, Steinmann J, Fiedler M, Steckel NK, Beelen DW, Liebregts T.

Biol Blood Marrow Transplant. 2018 Aug;24(8):1707-1714. doi: 10.1016/j.bbmt.2018.03.007. Epub 2018 Mar 14.

17.

Efficacy and safety of keratinocyte growth factor (palifermin) for prevention of oral mucositis in TBI-based allogeneic hematopoietic stem cell transplantation.

Schmidt V, Niederwieser D, Schenk T, Behre G, Klink A, Pfrepper C, Hinke A, Beelen DW, Junghanss C, Uharek L, Krüger WH, Hochhaus A, Sayer HG; East German Study Group for Hematology and Oncology (OSHO).

Bone Marrow Transplant. 2018 Sep;53(9):1188-1192. doi: 10.1038/s41409-018-0135-3. Epub 2018 Mar 15. No abstract available.

PMID:
29545592
18.

Elevated soluble human leukocyte antigen G levels in patients after allogeneic stem cell transplantation are associated with less severe acute and chronic graft-versus-host disease.

Kordelas L, da Silva Nardi F, Wagner B, Ditschkowski M, Liebregts T, Lindemann M, Heinemann FM, Horn PA, Beelen DW, Rebmann V.

Bone Marrow Transplant. 2018 Sep;53(9):1149-1156. doi: 10.1038/s41409-018-0145-1. Epub 2018 Mar 14.

PMID:
29540850
19.

High-dose melphalan-based sequential conditioning chemotherapy followed by allogeneic haematopoietic stem cell transplantation in adult patients with relapsed or refractory acute myeloid leukaemia.

Steckel NK, Groth C, Mikesch JH, Trenschel R, Ottinger H, Kordelas L, Mueller-Tidow C, Schliemann C, Reicherts C, Albring JC, Silling G, Schmidt E, Berdel WE, Lenz G, Ditschkowski M, Beelen DW, Stelljes M.

Br J Haematol. 2018 Mar;180(6):840-853. doi: 10.1111/bjh.15137. Epub 2018 Feb 21.

PMID:
29468631
20.

Assessing the risk of CMV reactivation and reconstitution of antiviral immune response post bone marrow transplantation by the QuantiFERON-CMV-assay and real time PCR.

Krawczyk A, Ackermann J, Goitowski B, Trenschel R, Ditschkowski M, Timm J, Ottinger H, Beelen DW, Grüner N, Fiedler M.

J Clin Virol. 2018 Feb - Mar;99-100:61-66. doi: 10.1016/j.jcv.2018.01.002. Epub 2018 Jan 9.

21.

The impact of HLA matching on outcomes of unmanipulated haploidentical HSCT is modulated by GVHD prophylaxis.

Lorentino F, Labopin M, Fleischhauer K, Ciceri F, Mueller CR, Ruggeri A, Shimoni A, Bornhäuser M, Bacigalupo A, Gülbas Z, Koc Y, Arcese W, Bruno B, Tischer J, Blaise D, Messina G, Beelen DW, Nagler A, Mohty M.

Blood Adv. 2017 Apr 21;1(11):669-680. doi: 10.1182/bloodadvances.2017006429. eCollection 2017 Apr 25.

22.

αβ-T-cell depleted donor lymphocyte infusion for leukemia relapse after allogeneic stem cell transplantation.

Kordelas L, Buttkereit U, Lindemann M, Koldehoff M, Klisanin V, Horn PA, Fleischhauer K, Beelen DW.

Bone Marrow Transplant. 2017 Dec;52(12):1668-1670. doi: 10.1038/bmt.2017.185. Epub 2017 Sep 4. No abstract available.

PMID:
28869619
23.

Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants.

Hehlmann R, Lauseker M, Saußele S, Pfirrmann M, Krause S, Kolb HJ, Neubauer A, Hossfeld DK, Nerl C, Gratwohl A, Baerlocher GM, Heim D, Brümmendorf TH, Fabarius A, Haferlach C, Schlegelberger B, Müller MC, Jeromin S, Proetel U, Kohlbrenner K, Voskanyan A, Rinaldetti S, Seifarth W, Spieß B, Balleisen L, Goebeler MC, Hänel M, Ho A, Dengler J, Falge C, Kanz L, Kremers S, Burchert A, Kneba M, Stegelmann F, Köhne CA, Lindemann HW, Waller CF, Pfreundschuh M, Spiekermann K, Berdel WE, Müller L, Edinger M, Mayer J, Beelen DW, Bentz M, Link H, Hertenstein B, Fuchs R, Wernli M, Schlegel F, Schlag R, de Wit M, Trümper L, Hebart H, Hahn M, Thomalla J, Scheid C, Schafhausen P, Verbeek W, Eckart MJ, Gassmann W, Pezzutto A, Schenk M, Brossart P, Geer T, Bildat S, Schäfer E, Hochhaus A, Hasford J.

Leukemia. 2017 Nov;31(11):2398-2406. doi: 10.1038/leu.2017.253. Epub 2017 Aug 14.

24.

Pretransplant Vitamin D Deficiency Is Associated With Higher Relapse Rates in Patients Allografted for Myeloid Malignancies.

Radujkovic A, Kordelas L, Krzykalla J, Beelen DW, Benner A, Lehners N, Schmidt K, Dreger P, Luft T.

J Clin Oncol. 2017 Sep 20;35(27):3143-3152. doi: 10.1200/JCO.2017.73.0085. Epub 2017 Aug 3.

PMID:
28771378
25.

A new tool for rapid and reliable diagnosis of HLA loss relapses after HSCT.

Ahci M, Toffalori C, Bouwmans E, Crivello P, Brambati C, Pultrone C, Stempelmann K, Bost D, Mazzi B, Beelen DW, Ciceri F, Mulder W, Fleischhauer K, Vago L.

Blood. 2017 Sep 7;130(10):1270-1273. doi: 10.1182/blood-2017-05-784306. Epub 2017 Jun 27. No abstract available.

26.

Clinical Utility of Quantitative PCR for Chimerism and Engraftment Monitoring after Allogeneic Stem Cell Transplantation for Hematologic Malignancies.

Ahci M, Stempelmann K, Buttkereit U, Crivello P, Trilling M, Heinold A, Steckel NK, Koldehoff M, Horn PA, Beelen DW, Fleischhauer K.

Biol Blood Marrow Transplant. 2017 Oct;23(10):1658-1668. doi: 10.1016/j.bbmt.2017.05.031. Epub 2017 Jun 8.

27.

Sensitive detection of rare antigen-specific T cells directed against Wilms' tumor 1 by FluoroSpot assay.

Danielzik T, Koldehoff M, Buttkereit U, Beelen DW, Horn PA, Lindemann M.

Leuk Lymphoma. 2018 Feb;59(2):490-492. doi: 10.1080/10428194.2017.1330955. Epub 2017 Jun 2. No abstract available.

PMID:
28573960
28.

Intestinal T lymphocyte homing is associated with gastric emptying and epithelial barrier function in critically ill: a prospective observational study.

Greis C, Rasuly Z, Janosi RA, Kordelas L, Beelen DW, Liebregts T.

Crit Care. 2017 Mar 22;21(1):70. doi: 10.1186/s13054-017-1654-9.

29.
30.

Allogeneic Stem Cell Transplantation for Patients Age ≥ 70 Years with Myelodysplastic Syndrome: A Retrospective Study of the MDS Subcommittee of the Chronic Malignancies Working Party of the EBMT.

Heidenreich S, Ziagkos D, de Wreede LC, van Biezen A, Finke J, Platzbecker U, Niederwieser D, Einsele H, Bethge W, Schleuning M, Beelen DW, Tischer J, Nagler A, Glass B, Maertens J, Yáñez L, Beguin Y, Sill H, Scheid C, Stelljes M, Ganser A, Zachée P, Selleslag D, de Witte T, Robin M, Kröger N.

Biol Blood Marrow Transplant. 2017 Jan;23(1):44-52. doi: 10.1016/j.bbmt.2016.09.027. Epub 2016 Oct 5.

31.

Emergence of linezolid- and vancomycin-resistant Enterococcus faecium in a department for hematologic stem cell transplantation.

Krull M, Klare I, Ross B, Trenschel R, Beelen DW, Todt D, Steinmann E, Buer J, Rath PM, Steinmann J.

Antimicrob Resist Infect Control. 2016 Sep 22;5:31. doi: 10.1186/s13756-016-0131-6. eCollection 2016.

32.

Early CMV-replication after allogeneic stem cell transplantation is associated with a reduced relapse risk in lymphoma.

Koldehoff M, Ross SR, Dührsen U, Beelen DW, Elmaagacli AH.

Leuk Lymphoma. 2017 Apr;58(4):822-833. doi: 10.1080/10428194.2016.1217524. Epub 2016 Aug 10.

PMID:
27687578
33.

Functional distance between recipient and donor HLA-DPB1 determines nonpermissive mismatches in unrelated HCT.

Crivello P, Heinold A, Rebmann V, Ottinger HD, Horn PA, Beelen DW, Fleischhauer K.

Blood. 2016 Jul 7;128(1):120-9. doi: 10.1182/blood-2015-12-686238. Epub 2016 May 9. Erratum in: Blood. 2016 Dec 8;128(23 ):2744.

34.

HLA mismatching as a strategy to reduce relapse after alternative donor transplantation.

Fleischhauer K, Beelen DW.

Semin Hematol. 2016 Apr;53(2):57-64. doi: 10.1053/j.seminhematol.2016.01.010. Epub 2016 Jan 15. Review.

PMID:
27000727
35.

Endoscopic and Histological Findings Are Predicted by Fecal Calprotectin in Acute Intestinal Graft-Versus-Host-Disease.

Adam B, Koldehoff M, Ditschkowski M, Gromke T, Hlinka M, Trenschel R, Kordeals L, Steckel NK, Beelen DW, Liebregts T.

Dig Dis Sci. 2016 Jul;61(7):2019-26. doi: 10.1007/s10620-016-4112-7. Epub 2016 Mar 19.

PMID:
26995779
36.

Allogeneic hematopoietic cell transplantation as curative therapy for non-transformed follicular lymphomas.

Heinzelmann F, Bethge W, Beelen DW, Engelhard M, Kröger N, Dreger P, Niederwieser D, Finke J, Bunjes D, Tischer J, Kobbe G, Holler E, Bornhäuser M, Stelljes M, Baurmann H, Müller A, Haubitz I, Schrezenmeier H, Müller C, Ottinger H.

Bone Marrow Transplant. 2016 May;51(5):654-62. doi: 10.1038/bmt.2015.348. Epub 2016 Feb 8.

PMID:
26855152
37.

Outcomes after use of two standard ablative regimens in patients with refractory acute myeloid leukaemia: a retrospective, multicentre, registry analysis.

Nagler A, Savani BN, Labopin M, Polge E, Passweg J, Finke J, Kyrcz-Krzemien S, Volin L, Anagnostopoulos A, Aljurf M, Beelen DW, Vigouroux S, Milpied N, Suarez F, Mohty M.

Lancet Haematol. 2015 Sep;2(9):e384-92. doi: 10.1016/S2352-3026(15)00146-5. Epub 2015 Aug 24.

PMID:
26685771
38.

Time-dependent effects of clinical predictors in unrelated hematopoietic stem cell transplantation.

Fuerst D, Mueller C, Beelen DW, Neuchel C, Tsamadou C, Schrezenmeier H, Mytilineos J.

Haematologica. 2016 Feb;101(2):241-7. doi: 10.3324/haematol.2015.130401. Epub 2015 Nov 26.

39.

Control of hepatitis B virus infection in hematopoietic stem cell recipients after receiving grafts from vaccinated donors.

Lindemann M, Koldehoff M, Fiedler M, Schumann A, Ottinger HD, Heinemann FM, Roggendorf M, Horn PA, Beelen DW.

Bone Marrow Transplant. 2016 Mar;51(3):428-31. doi: 10.1038/bmt.2015.253. Epub 2015 Oct 26. No abstract available.

PMID:
26501767
40.

CD34+ highly enriched allogeneic stem cell transplantation in a patient with mixed phenotype acute leukemia and Fusarium solani sepsis.

Kordelas L, Gromke T, Trenschel R, Ditschkowski M, Koldehoff M, Beelen DW.

Ann Hematol. 2016 Jan;95(1):155-156. doi: 10.1007/s00277-015-2504-y. Epub 2015 Sep 18. No abstract available.

PMID:
26382275
41.

Methylenetetrahydrofolate reductase polymorphism has no differential effect on the outcome of allogeneic hematopoietic stem cell transplant.

Koldehoff M, Beelen DW.

Leuk Lymphoma. 2015;56(8):2473-5. doi: 10.3109/10428194.2015.1006218. Epub 2015 Feb 9. No abstract available.

PMID:
25629983
42.

Treatment of acute myeloid leukemia or myelodysplastic syndrome relapse after allogeneic stem cell transplantation with azacitidine and donor lymphocyte infusions--a retrospective multicenter analysis from the German Cooperative Transplant Study Group.

Schroeder T, Rachlis E, Bug G, Stelljes M, Klein S, Steckel NK, Wolf D, Ringhoffer M, Czibere A, Nachtkamp K, Dienst A, Kondakci M, Stadler M, Platzbecker U, Uharek L, Luft T, Fenk R, Germing U, Bornhäuser M, Kröger N, Beelen DW, Haas R, Kobbe G.

Biol Blood Marrow Transplant. 2015 Apr;21(4):653-60. doi: 10.1016/j.bbmt.2014.12.016. Epub 2014 Dec 23.

43.

Shift of HIV tropism in stem-cell transplantation with CCR5 Delta32 mutation.

Kordelas L, Verheyen J, Beelen DW, Horn PA, Heinold A, Kaiser R, Trenschel R, Schadendorf D, Dittmer U, Esser S; Essen HIV AlloSCT Group.

N Engl J Med. 2014 Aug 28;371(9):880-2. doi: 10.1056/NEJMc1405805. No abstract available.

PMID:
25162903
44.

Impact of the International Prognostic Scoring System cytogenetic risk groups on the outcome of patients with primary myelodysplastic syndromes undergoing allogeneic stem cell transplantation from human leukocyte antigen-identical siblings: a retrospective analysis of the European Society for Blood and Marrow Transplantation-Chronic Malignancies Working Party.

Onida F, Brand R, van Biezen A, Schaap M, von dem Borne PA, Maertens J, Beelen DW, Carreras E, Alessandrino EP, Volin L, Kuball JH, Figuera A, Sierra J, Finke J, Kröger N, de Witte T; MDS subcommittee of the EBMT-CMWP.

Haematologica. 2014 Oct;99(10):1582-90. doi: 10.3324/haematol.2014.106880. Epub 2014 Aug 1.

45.

Conditioning with treosulfan and fludarabine for patients with refractory or relapsed non-Hodgkin lymphoma.

Schmitt M, Trenschel R, Sayer HG, Schneider C, Glass A, Hilgendorf I, Treschl A, Junghanss C, Borchert K, Koenigsmann M, Casper J, Beelen DW, Freund M, Kahl C.

Mol Clin Oncol. 2014 Sep;2(5):773-782. Epub 2014 Jun 2.

46.

Inhibition of mTOR with everolimus and silencing by vascular endothelial cell growth factor-specific siRNA induces synergistic antitumor activity in multiple myeloma cells.

Koldehoff M, Beelen DW, Elmaagacli AH.

Cancer Gene Ther. 2014 Jul;21(7):275-82. doi: 10.1038/cgt.2014.27. Epub 2014 Jun 6.

PMID:
24903015
47.

Explaining survival differences between two consecutive studies with allogeneic stem cell transplantation in patients with chronic myeloid leukemia.

Pfirrmann M, Saussele S, Hochhaus A, Reiter A, Berger U, Hossfeld DK, Nerl C, Scheid C, Spiekermann K, Mayer J, Hellmann A, Lechner K, Falge C, Sayer HG, Bunjes D, Ganser A, Beelen DW, Baldomero H, Schanz U, Heimpel H, Kolb HJ, Hasford J, Gratwohl A, Hehlmann R; Schweizerische Arbeitsgemeinschaft für Klinische Forschung (SAKK); German CML Study Group.

J Cancer Res Clin Oncol. 2014 Aug;140(8):1367-81. doi: 10.1007/s00432-014-1662-y. Epub 2014 Apr 10.

PMID:
24718719
48.

Human chorionic gonadotropin and indolamine 2,3-dioxygenase in patients with GVHD.

Elmaagacli AH, Ditschkowski M, Steckel NK, Gromke T, Ottinger H, Hillen U, Baba HA, Trenschel R, Beelen DW, Koldehoff M.

Bone Marrow Transplant. 2014 Jun;49(6):800-5. doi: 10.1038/bmt.2014.59. Epub 2014 Mar 31.

PMID:
24686986
49.

MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease.

Kordelas L, Rebmann V, Ludwig AK, Radtke S, Ruesing J, Doeppner TR, Epple M, Horn PA, Beelen DW, Giebel B.

Leukemia. 2014 Apr;28(4):970-3. doi: 10.1038/leu.2014.41. No abstract available.

PMID:
24445866
50.

Allogeneic transplantation versus chemotherapy as postremission therapy for acute myeloid leukemia: a prospective matched pairs analysis.

Stelljes M, Krug U, Beelen DW, Braess J, Sauerland MC, Heinecke A, Ligges S, Sauer T, Tschanter P, Thoennissen GB, Berning B, Kolb HJ, Reichle A, Holler E, Schwerdtfeger R, Arnold R, Scheid C, Müller-Tidow C, Woermann BJ, Hiddemann W, Berdel WE, Büchner T.

J Clin Oncol. 2014 Feb 1;32(4):288-96. doi: 10.1200/JCO.2013.50.5768. Epub 2013 Dec 23.

PMID:
24366930

Supplemental Content

Loading ...
Support Center